{"id":590,"date":"2022-02-01T09:00:18","date_gmt":"2022-02-01T09:00:18","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=1013430"},"modified":"2022-02-01T09:00:18","modified_gmt":"2022-02-01T09:00:18","slug":"medical-marijuana-inc-subsidiary-kannaway-opens-new-office-and-warehouse-in-johannesburg-south-africa","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2022\/02\/01\/medical-marijuana-inc-subsidiary-kannaway-opens-new-office-and-warehouse-in-johannesburg-south-africa\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary Kannaway\u00ae Opens New Office and Warehouse in Johannesburg, South Africa"},"content":{"rendered":"
SAN DIEGO, Feb. 01, 2022 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire<\/u><\/a>\u00a0—\u00a0Medical Marijuana, Inc.<\/u><\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary\u00a0Kannaway\u00ae<\/a>\u00a0has opened a new office and warehouse in South Africa.<\/p>\n The new 3,326 square foot combined facility is positioned just east of Johannesburg, making it convenient for employees and visitors to access. The facility allows Kannaway\u00ae to ship the company\u2019s full line of products throughout the country.<\/p>\n \u201cOur strategic decision to make South Africa a large focus for the Company\u2019s international growth this year comes with big ideas and even bigger execution,\u201d said Kannaway\u00ae CEO Blake Schroeder. \u201cThis new warehouse will allow us to reach more customers in the region and reduce our operating costs.\u201d<\/p>\n Recent reports<\/a>\u00a0from the Department of Agriculture, Land Reform, and Rural Development state that South Africa\u2019s cannabidiol (CBD) market is currently valued at around $1.9 billion and could create more than 25,000 jobs.<\/p>\n \u201cThis new office and warehouse is just our first step to greater expansion throughout Africa,\u201d said Duduzile Mathole, Kannaway\u00ae Country Manager, South Africa.<\/p>\n To learn more about Kannaway\u00ae, please visit the Company online at\u00a0https:\/\/www.kannaway.com\/<\/a>.<\/p>\n About Kannaway\u00ae<\/b> About Medical Marijuana, Inc.<\/b> Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.’s corporate video,\u00a0click here<\/a>.<\/p>\n FORWARD-LOOKING DISCLAIMER<\/b> FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/b> LEGAL DISCLOSURE<\/b>
\nKannaway\u00ae<\/a>\u00a0is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway\u00ae currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\n
\nWe are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.<\/p>\n
\nThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\n
\nThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.<\/p>\n
\nMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.<\/p>\n